The effect of high-energy extracorporeal shock waves on hyaline cartilage of adult rats in vivo

Journal of Orthopaedic Research

Volumn 28, Issue 8, 2010, Pages 1050-1056

  Mayer Wagner, Susanne ^a   Ernst, Judith ^a   Maier, Markus ^a   Chiquet, Matthias ^b   Joos, Helga ^c   Müller, Peter E ^a   Jansson, Volkmar ^a   Sievers, Birte ^a   Hausdorf, Jörg ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

Cartilage; Degeneration; ESWT; In vivo; Shock wave

Indexed keywords

CHITINASE 3 LIKE PROTEIN 1; COLLAGEN TYPE 2; COLLAGEN TYPE 2A1; GLYCOPROTEIN; MESSENGER RNA; TENASCIN; UNCLASSIFIED DRUG; CHI3L1 PROTEIN, RAT; SCLEROPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE INJURY; CELL DEATH; CELL MEMBRANE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; EXTRACORPOREAL LITHOTRIPSY; FEMUR HEAD; GENE EXPRESSION; HYALINE CARTILAGE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MANKIN SCORE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; ROUGH ENDOPLASMIC RETICULUM; SCORING SYSTEM; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BIOSYNTHESIS; GENETICS; METABOLISM; RADIATION; RADIOGRAPHY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ANIMALS; COLLAGEN TYPE II; EXTRACELLULAR MATRIX PROTEINS; FEMUR HEAD; GLYCOPROTEINS; HIGH-ENERGY SHOCK WAVES; HYALINE CARTILAGE; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; RATS; RATS, SPRAGUE-DAWLEY; TENASCIN;

EID: 77954752447     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21074     Document Type: Article

References (52)

1. Gerdesmeyer L, Wagenpfeil S, Haake M, et al. 2003. Extracorporeal shock wave therapy for the treatment of chronic calcifying tendonitis of the rotator cuff: a randomized controlled trial. JAMA 290:2573-2580. (Pubitemid 37443287)
2. Maier M, Steinborn M, Schmitz C, et al. 2001. Extracorporeal shock-wave therapy for chronic lateral tennis elbow - prediction of outcome by imaging. Arch Orthop Trauma Surg 121: 379-384. (Pubitemid 32684974)
3. Rompe JD. 2003. "Extracorporeal shock wave therapy for lateral epicondylitis - a double blind randomized controlled trial" by C.A. Speed et al. J Orthop Res 2002;20:895-898.
4. J Orthop Res 21:958-959.
5. Chen YJ, Wang CJ, Yang KD, et al. 2004. Extracorporeal shock waves promote healing of collagenase-induced Achilles tendinitis and increase TGF-beta1 and IGF-I expression. J Orthop Res 22:854-861.
6. Hsu RW, Hsu WH, Tai CL, et al. 2004. Effect of shock-wave therapy on patellar tendinopathy in a rabbit model. J Orthop Res 22:221-227. (Pubitemid 38035466)
7. Kudo P, Dainty K, Clarfield M, et al. 2006. Randomized, placebo-controlled, double-blind clinical trial evaluating the treatment of plantar fasciitis with an extracoporeal shock-wave therapy (ESWT) device: a North American confirmatory study. J Orthop Res 24:115-123. (Pubitemid 43773022)
8. Wang CJ, Wang FS, Ko JY, et al. 2008. Extracorporeal shockwave therapy shows regeneration in hip necrosis. Rheumatology (Oxford) 47:542-546.
9. Brissot R, Lassalle A, Vincendeau S, et al. 2005. [Treatment of heterotopic ossification by extracorporeal shock wave: 26 patients]. Ann Readapt Med Phys 48:581-589.
10. Rompe JD, Kirkpatrick CJ, Kullmer K, et al. 1998. Dose-related effects of shock waves on rabbit tendo Achillis. A sonographic and histological study. J Bone Joint Surg Br 80: 546-552. (Pubitemid 128472142)
11. Delius M, Draenert K, Al Diek Y, et al. 1995. Biological effects of shock waves: in vivo effect of high energy pulses on rabbit bone. Ultrasound Med Biol 21:1219-1225.
12. Maier M, Milz S, Tischer T, et al. 2002. Influence of extra-corporeal shock-wave application on normal bone in an animal model in vivo. Scintigraphy, MRI and histopathology. J Bone Joint Surg Br 84:592-599.
13. Kaulesar Sukul DM, Johannes EJ, Pierik EG, et al. 1993. The effect of high energy shock waves focused on cortical bone: an in vitro study. J Surg Res 54:46-51.
14. Yeaman LD, Jerome CP, McCullough DL. 1989. Effects of shock waves on the structure and growth of the immature rat epiphysis. J Urol 141:670-674. 1989.
15. Leicht S, Raum K. 2008. Acoustic impedance changes in cartilage and subchondral bone due to primary arthrosis. Ultrasonics 48:613-620.
16. Ogden JA, Toth-Kischkat A, Schultheiss R. 2001. Principles of shock wave therapy. Clin Orthop Relat Res 387:8-17.
17. Gerdesmeyer L, Maier M, Haake M, et al. 2002. [Physical-technical principles of extracorporeal shockwave therapy (ESWT)]. Orthopade 31:610-617.
18. Maier M, Schmitz C. 2008. Shock wave therapy: what really matters. Ultrasound Med Biol 34:1868-1869.
19. Vaterlein N, Lussenhop S, Hahn M, et al. 2000. The effect of extracorporeal shock waves on joint cartilage - an in vivo study in rabbits. Arch Orthop Trauma Surg 120: 403-406. (Pubitemid 30453685)
20. Murata R, Nakagawa K, Ohtori S, et al. 2007. The effects of radial shock waves on gene transfer in rabbit chondrocytes in vitro. Osteoarthritis Cartilage 15:1275-1282. (Pubitemid 350029036)
21. Lorenz H, Wenz W, Ivancic M, et al. 2005. Early and stable upregulation of collagen type II, collagen type I and YKL40 expression levels in cartilage during early experimental osteoarthritis occurs independent of joint location and histological grading. Arthritis Res Ther 7:R156-R165.
22. Mackie EJ. 1994. Tenascin in connective tissue development and pathogenesis. Perspect Dev Neurobiol 2:125-132.
23. Mackie EJ. 1997. Molecules in focus: tenascin-C. Int J Biochem Cell Biol 29:1133-1137.
24. Recklies AD, Ling H, White C, et al. 2005. Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes. J Biol Chem 280:41213-41221. (Pubitemid 41832176)
25. Aigner T, Bertling W, Stoss H, et al. 1993. Independent expression of fibril-forming collagens I, II, and III in chondrocytes of human osteoarthritic cartilage. J Clin Invest 91:829-837. (Pubitemid 23095256)
26. Wagner S, Hofstetter W, Chiquet M, et al. 2003. Early osteoarthritic changes of human femoral head cartilage subsequent to femoro-acetabular impingement. Osteoarthritis Cartilage 11:508-518. (Pubitemid 36747871)
27. Rosenberg L. 1971. Chemical basis for the histological use of safranin O in the study of articular cartilage. J Bone Joint Surg Am 53:69-82.
28. Mankin HJ, Dorfman H, Lippiello L, Zarins A. 1971. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 53:523-537.
29. Chiquet-Ehrismann R, Chiquet M. 2003. Tenascins: regulation and putative functions during pathological stress. J Pathol 200:488-499. (Pubitemid 36818249)
30. Lorenz H, Richter W. 2006. Osteoarthritis: cellular and molecular changes in degenerating cartilage. Prog Histochem Cytochem 40:135-163. (Pubitemid 43833326)
31. Salter DM. 1993. Tenascin is increased in cartilage and synovium from arthritic knees. Br J Rheumatol 32:780-786.
32. Veje K, Hyllested-Winge JL, Ostergaard K. 2003. Topographic and zonal distribution of tenascin in human articular cartilage from femoral heads: normal versus mild and severe osteoarthritis. Osteoarthritis Cartilage 11:217-227. (Pubitemid 36336427)
33. Chevalier X, Groult N, Larget-Piet B, et al. 1994. Tenascin distribution in articular cartilage from normal subjects and from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 37:1013-1022. (Pubitemid 24222092)
34. Chevalier X, Claudepierre P, Groult N, et al. 1996. Influence of interleukin 1 beta on tenascin distribution in human normal and osteoarthritic cartilage: a quantitative immuno-histochemical study. Ann Rheum Dis 55:772-775. (Pubitemid 26354441)
35. Murphy-Ullrich JE, Lightner VA, Aukhil I, et al. 1991. Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin. J Cell Biol 115:1127-1136. (Pubitemid 21909959)
36. Chiquet-Ehrismann R. 1991. Anti-adhesive molecules of the extracellular matrix. Curr Opin Cell Biol 3:800-804.
37. Fluck M, Tunc-Civelek V, Chiquet M. 2000. Rapid and reciprocal regulation of tenascin-C and tenascin-Y expression by loading of skeletal muscle. J Cell Sci 113(Pt 20):3583-3591.
38. Mehr D, Pardubsky PD, Martin JA, et al. 2000. Tenascin-C in tendon regions subjected to compression. J Orthop Res 18: 537-545.
39. Midwood K, Sacre S, Piccinini AM, et al. 2009. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med 15:774-780.
40. Volck B, Ostergaard K, Johansen JS, et al. 1999. The distribution of YKL-40 in osteoarthritic and normal human articular cartilage. Scand J Rheumatol 28:171-179. (Pubitemid 29298013)
41. Trudel G, Recklies A, Laneuville O. 2007. Increased expression of chitinase 3-like protein 1 secondary to joint immobility. Clin Orthop Relat Res 456:92-97. (Pubitemid 46662402)
42. Hakala BE, White C, Recklies AD. 1993. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 268:25803-25810. (Pubitemid 23358198)
43. Johansen JS, Olee T, Price PA, et al. 2001. Regulation of YKL- 40 production by human articular chondrocytes. Arthritis Rheum 44:826-837. (Pubitemid 32319775)
44. Haglund L, Bernier SM, Onnerfjord P, et al. 2008. Proteomic analysis of the LPS-induced stress response in rat chondrocytes reveals induction of innate immune response components in articular cartilage. Matrix Biol 27:107-118. (Pubitemid 351227379)
45. Nelson F, Dahlberg L, Laverty S, et al. 1998. Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest 102:2115-2125.
46. Burton-Wurster N, Hui-Chou CS, Greisen HA, et al. 1982. Reduced deposition of collagen in the degenerated articular cartilage of dogs with degenerative joint disease. Biochim Biophys Acta 718:74-84. (Pubitemid 13197476)
47. Lippiello L, Hall D, Mankin HJ. 1977. Collagen synthesis in normal and osteoarthritic human cartilage. J Clin Invest 59: 593-600. (Pubitemid 8078652)
48. Eyre D. 2002. Collagen of articular cartilage. Arthritis Res 4:30-35.
49. Lin PC, Wang CJ, Yang KD, et al. 2006. Extracorporeal shockwave treatment of osteonecrosis of the femoral head in systemic lupus erythematosis. J Arthroplasty 21:911-915. (Pubitemid 44293238)
50. Ludwig J, Lauber S, Lauber HJ, et al. 2001. High-energy shock wave treatment of femoral head necrosis in adults. Clin Orthop Relat Res 387:119-126. (Pubitemid 32510331)
51. Wang CJ, Kuo YR, Wu RW, et al. 2008. Extracorporeal Shockwave Treatment for Chronic Diabetic Foot Ulcers. J Surg Res.
52. Wang CJ, Wang FS, Yang KD, et al. 2008. Treatment of osteonecrosis of the hip: comparison of extracorporeal shock-wave with shockwave and alendronate. Arch Orthop Trauma Surg 128:901-908.